Ciclopirox (International)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D01AE14,G01AX12

CAS registry number (Chemical Abstracts Service)

0029342-05-0

Chemical Formula

C12-H17-N-O2

Molecular Weight

207

Therapeutic Categories

Antiseptic agent

Antifungal agent

Chemical Name

2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-metyl-

Foreign Names

• Ciclopiroxum (Latin)
• Ciclopirox (German)
• Ciclopirox (French)
• Ciclopirox (Spanish)

Generic Names

• Ciclopirox (OS: BAN, DCF, USAN, DCIT)
• HOE 296b (IS)
• Ciclopirox (PH: BP 2018, Ph. Eur. 9, USP 41)
• Ciclopiroxum (PH: Ph. Eur. 9)
• Ciclopirox Olamine (OS: BANM, USAN, JAN)
• Ciclopirox ethanolamine (IS)
• Cyclopiroxolamine (IS)
• Hoe 296 (HoechstMarion) (IS)
• Ciclopirox olamin (PH: Ph. Eur. 9)
• Ciclopirox Olamine (PH: BP 2018, USP 41)
• Ciclopirox olamine (PH: Ph. Eur. 9)
• Ciclopiroxum olaminum (PH: Ph. Eur. 9)

Brand Names

• 8X
  Cipla, India
• 8X [+ Pyrithione Zinc]
  Cipla, India
• Apo-Ciclopirox
  Apotex, Canada; Apotex, Hong Kong; Apotex, New Zealand
• Axopirox
  Axxon, Poland
• Batrafan
  Sanofi Aventis, India
• Batrafen
  Sanofi Israel, Israel; Sanofi-Aventis, Austria; Sanofi-Aventis, Bulgaria; Sanofi-Aventis, Cyprus; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Hungary; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Lithuania; Sanofi-Aventis Deutschland, Germany; Sanofi-Aventis Group, Russian Federation; Shandong Dermik, China
• Batrafen 1%
  Sanofi-Aventis, Egypt
• Batrafen 8%
  Sanofi-aventis, Cyprus
• Batrafen S
  Sanofi-aventis, Cyprus
• Batrafen S 10mg/g
  Sanofi-Aventis Deutschland, Germany
• Batrafen Unghie
  Sanofi-Aventis, Italy
• Ciclocutan 80 mg/g
  Dermapharm, Austria; Dermapharm, Switzerland
• Cicloderm
  Trima, Israel
• Ciclopirox
  Bergamo, Brazil
• Ciclopirox Biogaran 8%
  Biogaran, France
• Ciclopirox Mylan 8%
  Mylan, France
• Ciclopirox Serra
  Serra Pamies, Spain
• Ciclopirox SteriMax
  SteriMax, Canada
• Ciclopirox Teva 8 %
  Teva Santé, France
• Ciclopirox Winthrop
  Zentiva Pharma, Germany
• Ciclopoli
  Almirall Hermal, Germany; Polichem, Israel
• Ciclopoli 8%
  Polichem, Switzerland
• Cyclopoli
  Alfa Wassermann, Russian Federation
• Dafnegin
  Polichem, Romania
• Flucort-C [+ Fluocinolone Acetonide]
  Glenmark Pharmaceuticals, Vietnam
• Fluticare-C [+ Fluticasone]
  Hetero, India
• Funamix
  Advaita, Mexico
• Funginail
  Perrigo, Israel
• Huanli
  Twinluck Pharmaceutical, China
• Kelual DS
  P.F.Dermo-Cosm., Argentina
• Kitonail
  Almirall, Spain; Castalia Laboratoires Dermatologiques, Greece; Polichem, Romania
• Kitonail 80 mg/g
  Polichem, Austria; Polichem, Hungary
• Kurergan
  Polichem, Lithuania
• Loprox
  Medimetriks, United States; Sanofi-Aventis, Argentina; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Mexico
• Loprox NL
  Sanofi-Aventis Farmaceutica, Brazil
• Miclast
  Pierre Fabre Dermo, Germany; Pierre Fabre Iberica, Spain
• Micolamina
  Theraskin, Brazil
• Micomazol Laca
  Investi, Argentina
• Micopirox
  D & M Pharma, Chile; D&M Pharma, Peru; Lersan, Argentina; MediHealth, Uruguay; Pablo Cassara, Paraguay
• Micopirox Laca
  Lersan, Argentina
• Mycomycen
  Verisfield, Cyprus
• Mycomycen 1%
  Verisfield, Cyprus
• Myconail
  Bailleul, France; Laboratoire Bailleul-Biorga, Belgium; Perrigo, Israel
• Mycosten
  Pierre Fabre Dermatologie, Poland; Pierre Fabre Sante, Belgium
• Mycoster
  Pierre Fabre, Lebanon; Pierre Fabre Dermatologie, France
• Mycoster 1%
  GNP, Egypt; Pierre Fabre, Luxembourg
• Mycoster 8%
  Pierre Fabre, Israel; Pierre Fabre, Vietnam; Pierre Fabre Dermatologie, France
• Nagel Batrafen
  Sanofi-Aventis Deutschland, Germany
• Nagel Batrafen A
  Sanofi-Aventis Deutschland, Germany
• Nibulen
  Sanofi Sağlik, Turkey
• Niogermos
  ISDIN, Portugal
• Niogermox
  Isdin, Argentina
• Olamin
  Micro Gratia, India
• Onylac
  Cipla, India
• Onytec
  Almirall, Denmark; Almirall, Norway; Almirall, Sweden; Bailleul, France; MedLinija, Lithuania; Polichem, Estonia; Polichem, Lithuania; Polichem, Latvia; Polichem, Slovenia
• Ony-Tec
  Bago, Peru; Medea, Spain
• Oxolam
  Mibe Pharmaceuticals, Croatia (Hrvatska)
• Penlac
  Valeant Canada, Canada; Valeant Pharmaceuticals International, United States
• Pirolam
  Medana Pharma, Poland
• PMS-Ciclopirox
  Pharmascience, Canada
• Polinail
  Alfa Wassermann, Bulgaria; Alfasigma, Slovakia; Doppel, Bulgaria; Polichem, Czech Republic; Polichem, Poland
• Privex
  Laboratorio Bago, Chile
• Rejuvenail
  A Menarini Australia, Australia
• Roxolac
  Pierre Fabre Italia, Italy
• Stieprox
  GlaxoSmithKline, India
• Stieprox 1.5%
  GlaxoSmithKline, Cyprus
• Taro-Ciclopirox
  Taro Pharmaceutical Industries, Canada
• Tineapirox 1%
  Mepaco, Egypt
• Batrafen
  Aventis, Russian Federation; Sanofi, Dominican Republic; Sanofi, Guatemala; Sanofi, Panama; Sanofi Aventis, Chile; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Honduras; Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Italy; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Peru; Sanofi-Aventis, Paraguay; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Uruguay; Sanofi-Aventis, Venezuela; Sanofi-Aventis Deutschland, Germany; Sanofi-Aventis, Poland
• Batrafen 1%
  Alfresa Pharma, Japan; sanofi-aventis, Venezuela
• Bioginal
  So.Se. Pharm, Italy
• Brumixol
  Bruschettini, Italy; Bruschettini, Lebanon; Bruschettini, Malta; Bruschettini, Taiwan
• Canolen
  Metin Ecza, Turkey
• Celamina
  Glenmark, Peru
• Celamina Ultra [+ Pyrithione Zinc, + Salicylic Acid]
  Glenmark, Brazil
• Celamina Zinco [+ Pyrithione Zinc]
  Glenmark, Brazil; Glenmark, Peru
• Ciclochem
  Ferrer Internacional, Spain
• Ciclocutan
  Dermapharm, Switzerland; Dermapharm, Germany
• Cicloderm
  Trima, Israel
• Cicloderm-C [+ Clobetasone, + Gentamicin]
  Trima, Israel
• Ciclokrem
  Sun-Farm, Poland
• Ciclolack
  Sun-Farm, Poland
• Ciclopirox acis
  acis Arzneimittel, Germany
• Ciclopirox acis 1%
  acis Arzneimittel, Germany
• Ciclopirox acis bei Hautpilzerkrankungen
  acis Arzneimittel, Germany
• Ciclopirox HEXAL 1%
  Hexal, Germany
• Ciclopirox Isdin
  Isdin, Spain
• Ciclopirox Olamina Abamed
  Abamed, Spain
• Ciclopirox Olamina Biogalenica
  Pierre Fabre Iberica, Spain
• Ciclopirox Olamina Capitec
  Medea, Spain
• Ciclopirox Olamina EMS
  EMS, Brazil
• Ciclopirox Olamina Gen.Germed
  Genéric.Germed, Brazil
• Ciclopirox Olamina Gen.Legrand
  Genéric.Legrand, Brazil
• Ciclopirox Olamina Globo
  Globo, Brazil
• Ciclopirox Olamina Isdin
  Isdin, Spain
• Ciclopirox Olamina Medley
  Medley, Brazil
• Ciclopirox Olamina Pharlab
  Pharlab, Brazil
• Ciclopirox Olamina Prati,Donad
  Prati, Donaduzzi, Brazil
• Ciclopirox Olamina Serra
  Serra Pamies, Spain
• Ciclopirox Olamine Biogaran 1%
  Biogaran, France
• Ciclopirox Olamine Sandoz 1%
  Sandoz, France
• Ciclopirox Olamine Teva 1%
  Teva Santé, France
• Ciclopirox Polichem
  Polichem, Italy
• Ciclopiroxolamina 10mg Landa
  Landa, Paraguay
• Ciclopiroxolamina Dutriec
  Dutriec, Paraguay
• Ciclopirox-ratiopharm 1%
  ratiopharm, Germany
• Ciclopoli
  Almirall Hermal, Germany; Polichem, Italy
• Ciclotau
  Alfa Wassermann, Bulgaria; Polichem, Estonia; Polichem, Poland
• Dafnegil 100mg
  Medinova, Switzerland
• Dafnegil 10mg/g
  Medinova, Switzerland
• Dafnegil 6+40g
  Medinova, Switzerland
• Dafnegin
  Doppel, China; Marvecs Pharma Services, Italy; Pharmex, Greece; Polichem, Czech Republic; Polichem, Poland; Sanital, Pakistan; Scharper, Pakistan
• Flucort-C [+ Fluocinolone Acetonide]
  Glenmark, India
• Fungirox
  UCI-Farma, Brazil
• Fungopirox 1%
  Royal Pharma, Chile
• Fungowas
  Chiesi, Spain
• Hascofungin
  Hasco-Lek, Poland
• Loprox
  Bipharma, Netherlands; Gensu Pharma, Turkey; Medicis, United States; Sanofi-Aventis, Mexico; Sanofi-Aventis, Thailand; Sanofi-Aventis Farmaceutica, Brazil; Valeant Canada, Canada
• Miclast
  Pierre Fabre, Turkey; Pierre Fabre Italia, Italy
• Micomicen
  Sanofi-Aventis, Italy
• Micopirox 1%
  D & M Pharma, Chile
• Micopirox 8%
  D & M Pharma, Chile
• Micoxolamina
  Mastelli, Italy
• Mupirox
  EMS, Brazil
• Mycomycen
  Verisfield, Greece
• Mycomycen 1%
  Verisfield, Greece
• Mycomycen 8%
  Verisfield, Greece
• Mycorex
  Opalia, Tunisia
• Mycoskin 1%
  Bailleul, France
• Mycosten
  Pierre Fabre Dermatologie, Poland; Pierre Fabre Sante, Belgium
• Mycoster
  Pierre Fabre, Portugal; Pierre Fabre, Tunisia; Simed, Tunisia
• Mycoster 1%
  Pierre Fabre, Vietnam; Pierre Fabre Dermatologie, France
• Mycoster 10mg/g
  Pierre Fabre, Switzerland
• Neo-Botacreme
  Target Pharma, Greece
• Neo-Mycodermol
  Adelco, Greece
• Nibulen
  Sanofi Sağlik, Turkey
• Nobiprox
  Taiguk, South Korea
• Obytin
  Jugoremedija, Macedonia; Union-Medic, Serbia
• Olamin-F [+ Fluocinolone Acetonide]
  Micro Gratia, India
• Opilox
  Farma-Tek, Turkey
• Pirolam
  Medana Pharma, Poland
• Primax 1%
  Bussié, Colombia; Bussié, Honduras
• Sai Jie
  Keyi Pharmaceutical, China
• Sebiprox
  GlaxoSmithKline, Switzerland; Stiefel, Spain; Stiefel, Italy; Stiefel, Portugal; Stiefel, Tunisia
• Sebiprox 1.5%
  GlaxoSmithKline, Germany; GlaxoSmithKline Laboratoire Pharmaceutique, France; Stiefel, Germany
• Sebirox
  Avixa, Turkey
• Siroksil
  Abdi Ibrahim, Turkey
• Stieprox
  GlaxoSmithKline, Canada; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Singapore; GlaxoSmithKline A.B.E.E., Greece; Stiefel, Ireland; Stiefel, Malaysia; Stiefel, Philippines; Stiefel, Slovakia; Stiefel, Taiwan; Stiefel Laboratories Polska Sp. z.o.o., Poland; GlaxoSmithKline, Lithuania
• Stieprox 1,5%
  GlaxoSmithKline Pharma, Austria
• Stieprox 1.5%
  Stiefel, Oman
• Stiprox
  Stiefel, Brazil
• Stiprox 1.5%
  Stiefel, Paraguay
• Tineax
  Solebio, Turkey

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer